Anuj Bhardwaj on the noninvasive ultrasound therapy for treating inflammation and pain from SecondWave Systems

Anuj Bhardwaj is the CEO of SecondWave Systems which is a wearable ultrasound noninvasive therapy especially for suppressing chronic inflammation and pain signals.

***This podcast is sponsored by Iris Biomedical, check out their Neurotech Startup Services here***

Top 3 Takeaways:

•  "We're going to use a disposable coupling component that a patient uses to adhere this and couple it to the body for 18 minutes while they remain in a reasonably sedentary condition. They would do that once a day."
• "The cost of the healthcare system is often between one to $200,000 per year for patients that take biologics like Enbrel. So that's a huge burden on the system"

• "My advice to other companies like us would be to look at the SBIR program. We're very strong advocates of it. It's really been the main engine that launched us. I'd advise looking at NIH, BARDA, and others too. Then consider if they fit within the mission of what a company is doing and apply."

0:30 "Do you want to describe yourself and your technology?"

2:30 "Let's talk about the technology, who's it for?"

9:15 Iris Biomedical ad sponsorship

10:15 "You're not using electricity, but you're using ultrasound, which is something that's a little bit more rarely used. Why are you using this and how does it work?"

12:15 "What kind of treatments would you guys be able to provide?"

15:30 "So what fraction of the $100,000-$200,000 / year Rheumatoid Arthritis costs would you guys represent?"

16:30 Do you want to talk about the FDA approval process for a wearable?

18:15 Do you want to talk about your sources of funding so far?

22:30 "What is one of the biggest challenges in this work?"

25:00 "Are you looking for people to join or are you looking for anything in particular?"